Position in KRYS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$12,139,485
+$4,483,397 QoQ
Shares Held
32,662
+10.2% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#75
of 419 holders
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRUDENTIAL FINANCIAL INC holds $556,047,667 across 189 Biotechnology names. KRYS ranks #9 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
130,659 | $81,471,112 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
133,294 | $66,211,127 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
392,811 | $22,476,644 | |
| 4 | INCY |
Incyte Corp
|
191,312 | $21,687,128 | |
| 5 | CYTK |
Cytokinetics Inc
|
214,535 | $18,276,236 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
54,623 | $17,265,784 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
185,820 | $15,157,337 | |
| 8 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
2,152,154 | $13,429,440 |
All Filings in KRYS
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,139,485 | 32,662 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $7,656,088 | 29,638 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $6,660,278 | 27,015 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $4,500,808 | 25,496 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,594,716 | 26,151 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $4,924,173 | 27,311 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $6,453,295 | 41,193 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $6,906,035 | 37,939 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $8,546,238 | 46,538 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $6,733,760 | 37,845 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $4,907,317 | 39,556 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $4,591,976 | 39,586 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,137,723 | 9,691 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $403,705 | 5,096 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $550,002 | 7,891 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $718,386 | 10,941 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,390,087 | 20,891 | Shares | Defined | 2022-05-13 | |
| No filing history on record for this holder in this stock. | ||||||